Private Market View

Lyobead

Suzhou, China · Founded 2022 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Tahoe Venture.
  • Status: Privately Held (backing).

Investors

1
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Lyobead
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Lyobead are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Lyobead

Manufacturer of lyophilised reagents and biomaterials, specializing in contract development and manufacturing for liquid-based life science products. The company specailises in lyophilised bead formulation, reagent stabilisation, biomaterial preservation and on-demand CDMO services, thereby reducing storage costs, improving product quality, and supporting scalable reagent development.

Sector
Business Products and Services (B2B)
HQ
Suzhou, China
Founded
2022
Ownership
Privately Held (backing)
PA Mark — not yet priced

Lyobead doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Lyobead shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Lyobead in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.